RAYMOND JAMES & ASSOCIATES - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 49 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$27,000
-34.1%
10,2550.0%0.00%
Q2 2021$41,000
-16.3%
10,2550.0%0.00%
Q1 2021$49,000
-57.4%
10,255
-36.9%
0.00%
Q4 2020$115,000
-70.1%
16,264
-55.4%
0.00%
Q3 2020$384,000
+152.6%
36,467
+111.8%
0.00%
Q2 2020$152,000
+280.0%
17,218
+57.7%
0.00%
Q1 2020$40,000
-7.0%
10,9180.0%0.00%
Q4 2019$43,000
-6.5%
10,918
-11.0%
0.00%
Q3 2019$46,00012,2680.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MEITAV INVESTMENT HOUSE LTD 167,593$131,0000.00%
IFP Advisors, Inc 662$17,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders